In Q3 2025, Cardinal Health, Inc. (CAH) reported quarterly revenue of $65.6 billion and net income of $467 million. This represents a strong improvement over the previous quarter, with revenue growth of 2.53% and profit growth of 1.19%. Compared to the same period last year, CAH experienced impressive revenue growth of 18.75% and profit growth of 43.96%, outperforming the sector averages in both categories.
The company's strong financial performance is further reflected by its 3-year revenue CAGR of 2.78% and 3-year profit CAGR of 9.08%. Notably, CAH has maintained consecutive growth quarters for three straight periods, demonstrating a robust momentum in its operations. Additionally, the company's operating margin of 1.13% and net margin of 0.68% are both above average for the healthcare sector, indicating that CAH is effectively managing its costs and generating solid returns.
Recent news suggests that CAH stock is experiencing a bullish outlook due to its strong Q2 results and raised guidance. The company's Adjusted EPS of $2.63 beat consensus estimates by $0.12, contributing to the stock's 9.11% increase in value and reaching a new 52-week high. These positive developments indicate that CAH is well-positioned to continue its growth trajectory and generate attractive returns for investors.
While there are no clear risk factors identified for CAH at this time, it's essential to consider the broader economic environment and potential regulatory changes that could impact the healthcare sector. Nonetheless, given the company's solid financial performance, consistent growth, and positive news sentiment, CAH remains an attractive investment opportunity for those looking to diversify their portfolio within the healthcare sector.
Moving forward, CAH should continue to focus on maintaining its operational efficiency, expanding its product offerings, and capitalizing on emerging market opportunities. By doing so, the company can sustain its growth momentum and create long-term value for its shareholders. Overall, CAH's strong financial performance, positive news sentiment, and robust growth prospects make it a compelling investment opportunity in the healthcare sector.